Current Report Filing (8-k)
28 August 2019 - 3:20AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of
Report (Date of earliest event reported)
August 21, 2019
AEHR TEST SYSTEMS
(Exact
name of registrant as specified in its charter)
California
|
|
000-22893
|
|
94-2424084
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
400 KATO TERRACE, FREMONT, CA 94539
|
(Address
of principal executive offices, including zip code)
|
|
510-623-9400
|
(Registrant’s
telephone number, including area code)
|
|
N/A
|
(Former
name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
|
Name of
each exchange on which registered
|
|
Symbol(s)
|
|
Common
Stock
|
AEHR
|
The
NASDAQ Capital Market
|
Item 3.01 Notice of Delisting or
Failure to Satisfy a Continued Listing Rule or Standard; Transfer
of Listing.
On
August 21, 2019, Aehr Test Systems (the “Company”)
provided to the NASDAQ Stock Market (“NASDAQ”) notice
that, as a result of the vacancies on the
audit committee (the “Audit
Committee”) of the Company’s Board of Directors (the
“Board”) and the compensation committee (the
“Compensation Committee”) of the Board created by the
death of Dr. William W. R. Elder, OBE on August 17, 2019, the
Company no longer complies with NASDAQ Listing Rule 5605(c)(2)(A),
which requires that the Audit Committee be comprised of at least
three directors who meet certain independence and other
requirements, and NASDAQ Listing Rule 5605(d)(2)(A), which requires
that the Compensation Committee be comprised of at least two
directors who meet certain independence and other requirements. The
Company is required to regain compliance by (i) the earlier of the
Company’s next annual meeting of shareholders or August 17,
2020 or (ii) if the Company’s next annual meeting of
shareholders is held before February 13, 2020, then February 13,
2020. The Company intends to take all necessary steps to regain
compliance by the end of the cure period.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Aehr Test
Systems
(Registrant)
|
|
|
|
|
|
Date:
August
27, 2019
|
By:
|
/s/ Kenneth B.
Spink
|
|
|
|
Kenneth B.
Spink
|
|
|
|
Vice President of
Finance and Chief Financial Officer
|
|
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Apr 2024 to May 2024
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From May 2023 to May 2024